NP / PA
Maynard, Michaela
Maynard, Michaela was paid $518K by Medicaid between Mar 2018 and Jul 2024, across 14 billing codes. Its largest line is 87591, Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe — 36% of everything it billed.
33Billing provider infoMAYNARD, MICHAELA
PROVIDENCE, RI 02904
PROVIDENCE, RI 02904
33aNPI1083090849assigned 08/04/2015
33bProvider typeAdult Health Nurse Practitioner
28Total paid$518K
24GClaims6,323
24DCodes billed14
24AFirst – last monthMar 2018 – Jul 2024
Compared with peers
Next to other Adult Health Nurse Practitioner providers in Rhode Island
Rank by total paid#1 of 49
Median peer was paid$27K
This provider vs. median19×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 1,207 | $112K | |
| 2019 | 1,653 | $163K | |
| 2020 | 1,432 | $134K | |
| 2021 | 509 | $48K | |
| 2022 | 472 | $30K | |
| 2023 | 817 | $23K | |
| 2024incomplete | 233 | $7K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 36% | 1,204 | 942 | $188K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 36% | 1,191 | 928 | $188K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 8.0% | 907 | 742 | $41K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 7.5% | 685 | 623 | $39K |
| 86780 | 5.3% | 877 | 694 | $28K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 2.8% | 758 | 657 | $14K |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | 1.4% | 124 | 107 | $7K |
| 36415 | Collection of venous blood by venipuncture | 1.2% | 344 | 304 | $6K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | <1% | 22 | 18 | $2K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 15 | 14 | $1K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | <1% | 13 | 13 | $897.85 |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 92 | 84 | $874.42 |
2 more codes
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.